Jeffrey R. Deschamps

Structure-Based Design of Potent Non-Peptide MDM2 Inhibitors

Ke Ding, Yipin Lu, Zaneta Nikolovska‐Coleska et al. · Journal of the American Chemical Society · 2005 · 643 citations

Molecular Docking, Medicinal Chemistry, Drug Target +15

A Hybrid Quantum Dot−Antibody Fragment Fluorescence Resonance Energy Transfer-Based TNT Sensor

Ellen R. Goldman, Igor L. Medintz, Jessica L. Whitley et al. · Journal of the American Chemical Society · 2005 · 566 citations

Nanomedicine, Photonic Sensor, Proximity-induced Fret +13

Proteolytic activity monitored by fluorescence resonance energy transfer through quantum-dot–peptide conjugates

Igor L. Medintz, Aaron R. Clapp, Florence M. Brunel et al. · Nature Materials · 2006 · 542 citations

Quantum-dot–peptide Conjugates, Proteolytic Activity, Biochemistry +7

1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) Analogues:  A Promising Class of Monoamine Uptake Inhibitors

Peter C. Meltzer, David Butler, Jeffrey R. Deschamps et al. · Journal of Medicinal Chemistry · 2006 · 399 citations · Full text

Monoamine Uptake Inhibitors, Pharmacotherapy, Lead Compound +16

Peripheral Cannabinoid-1 Receptor Inverse Agonism Reduces Obesity by Reversing Leptin Resistance

Joseph Tam, Jie Liu, Grzegorz Godlewski et al. · Cell Metabolism · 2012 · 342 citations · Full text

Obesity, Metabolic Syndrome, Cannabis Use +11